Interleukin-17A exacerbates ferric chloride-induced arterial thrombosis in rat carotid artery

International Journal of Inflammation

Volumn 2014, Issue , 2014, Pages

  Maione, Francesco ^a   Parisi, Antonio ^a   Caiazzo, Elisabetta ^a   Morello, Silvana ^b   D'Acquisto, Fulvio ^c   Mascolo, Nicola ^a   Cicala, Carla ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF SALERNO   (Italy)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; CD39 ANTIGEN; FERRIC CHLORIDE; INTERLEUKIN 17;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL WALL THICKNESS; ARTICLE; CAROTID ARTERY THROMBOSIS; CONTROLLED STUDY; DOWN REGULATION; HYDROLYSIS; MALE; NONHUMAN; RAT; VASCULAR ENDOTHELIUM;

EID: 84899541123     PISSN: 20908040     EISSN: 20420099     Source Type: Journal    
DOI: 10.1155/2014/247503     Document Type: Article

References (31)

1. Frostegard J., Atherosclerosis in patients with autoimmune disorders. Arteriosclerosis, Thrombosis, and Vascular Biology 2005 25 9 1776 1785 10.1161/01.ATV.0000174800.78362.ec
2. Cicala C., Cirino G., Linkage between inflammation and coagulation: an update on the molecular basis of the crosstalk. Life Sciences 1998 62 20 1817 1824 2-s2.0-0032502978 10.1016/S0024-3205(97)01167-3
3. Strukova S., Blood coagulation-dependent inflammation. Coagulation-dependent inflammation and inflammation-dependent thrombosis. Frontiers in Bioscience 2006 11 1 59 80 2-s2.0-32844471084 10.2741/1780
4. Fägerstam J. P., Whiss P. A., Ström M., Andersson R. G., Expression of platelet P-selectin and detection of soluble P-selectin, NPY and RANTES in patients with inflammatory bowel disease. Inflammation Research 2000 49 9 466 472 2-s2.0-0033798272 10.1007/s000110050618
5. Mameli A., Barcellona D., Marongiu F., Rheumatoid arthritis and thrombosis. Clinical and Experimental Rheumatology 2009 27 5 846 855 2-s2.0-72949113401
6. Mac Mullan P. A., Peace A. J., Madigan A. M., Tedesco A. F., Kenny D., McCarthy G. M., Platelet hyper-reactivity in active inflammatory arthritis is unique to the adenosine diphosphate pathway: a novel finding and potential therapeutic target. Rheumatology 2009 49 2 240 245 2-s2.0-77950407295 10.1093/rheumatology/kep377
7. Nurden A. T., Platelets, inflammation and tissue regeneration. Thrombosis and Haemostasis 2011 105 supplement 1 S13 S33 10.1160/THS10-11-0720
8. Engelmann B., Massberg S., Thrombosis as an intravascular effector of innate immunity. Nature Reviews Immunology 2013 13 1 34 45 10.1038/nri3345
9. D'Acquisto F., Maione F., Pederzoli-Ribeil M., From IL-15 to IL-33: the never-ending list of new players in inflammation. Is it time to forget the humble aspirin and move ahead? Biochemical Pharmacology 2010 79 4 525 534 2-s2.0-71349086708 10.1016/j.bcp.2009.09.015
10. Onishi R. M., Gaffen S. L., Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease. Immunology 2010 129 3 311 321 2-s2.0-75949102667 10.1111/j.1365-2567.2009.03240.x
11. Iwakura Y., Ishigame H., Saijo S., Nakae S., Functional specialization of interleukin-17 family members. Immunity 2011 34 2 149 162 2-s2.0-79951743212 10.1016/j.immuni.2011.02.012
12. Maione F., Paschalidis N., Mascolo N., Dufton N., Perretti M., D'Acquisto F., Interleukin 17 sustains rather than induces inflammation. Biochemical Pharmacology 2009 77 5 878 887 2-s2.0-59749106381 10.1016/j.bcp.2008.11.011
13. Chen X. Q., Yu Y. C., Deng H. H., Sun J. Z., Dai Z., Wu Y. W., Yang M., Plasma IL-17A is increased in new-onset SLE patients and associated with disease activity. Journal of Clinical Immunology 2010 30 2 221 225 2-s2.0-77953536871 10.1007/s10875-009-9365-x
14. Leipe J., Grunke M., Dechant C., Reindl C., Kerzendorf U., Schulze-Koops H., Skapenko A., Role of Th17 cells in human autoimmune arthritis. Arthritis & Rheumatism 2010 62 10 2876 2885 2-s2.0-77957689108 10.1002/art.27622
15. Zhao X.-F., Pan H.-F., Yuan H., Zhang W.-H., Li X.-P., Wang G.-H., Wu G.-C., Su H., Pan F.-M., Li W.-X., Li L.-H., Chen G.-P., Ye D.-Q., Increased serum interleukin 17 in patients with systemic lupus erythematosus. Molecular Biology Reports 2010 37 1 81 85 2-s2.0-77949264323 10.1007/s11033-009-9533-3
16. Smith E., Prasad K. M., Butcher M., Dobrian A., Kolls J. K., Ley K., Galkina E., Blockade of interleukin-17A results in reduced atherosclerosis in apolipoprotein E-deficient mice. Circulation 2010 121 15 1746 1755 2-s2.0-77951485998 10.1161/CIRCULATIONAHA.109.924886
17. Cheng X., Yu X., Ding Y.-J., Fu Q.-Q., Xie J.-J., Tang T.-T., Yao R., Chen Y., Liao Y.-H., The Th17/Treg imbalance in patients with acute coronary syndrome. Clinical Immunology 2009 127 1 89 97 10.1016/j.clim.2008.01.009
18. Eid R. E., Rao D. A., Zhou J., Lo S. F., Ranjbaran H., Gallo A., Sokol S. I., Pfau S., Pober J. S., Tellides G., Interleukin-17 and interferon- γ are produced concomitantly by human coronary artery-infiltrating T cells and act synergistically on vascular smooth muscle cells. Circulation 2009 119 10 1424 1432 2-s2.0-64549126102 10.1161/CIRCULATIONAHA.108.827618
19. Marder W., Khalatbari S., Myles J. D., Hench R., Yalavarthi S., Lustig S., Brook R., Kaplan M. J., Interleukin 17 as a novel predictor of vascular function in rheumatoid arthritis. Annals of the Rheumatic Diseases 2011 70 9 1550 1555 2-s2.0-80051471106 10.1136/ard.2010.148031
20. Hot A., Lenief V., Miossec P., Combination of IL-17 and TNF α induces a pro-inflammatory, pro-coagulant and pro-thrombotic phenotype in human endothelial cells. Annals of the Rheumatic Diseases 2012 71 5 768 776 2-s2.0-84859491118 10.1136/annrheumdis-2011-200468
21. Ruggeri Z. M., Platelet interactions with vessel wall components during thrombogenesis. Blood Cells, Molecules, and Diseases 2006 36 2 145 147 2-s2.0-33645295529 10.1016/j.bcmd.2005.12.012
22. Maione F., Cicala C., Liverani E., Mascolo N., Perretti M., D'Acquisto F., IL-17A increases ADP-induced platelet aggregation. Biochemical and Biophysical Research Communications 2011 408 4 658 662 2-s2.0-79956219285 10.1016/j.bbrc.2011.04.080
23. Garbaraviciene J., Diehl S., Varwig D., Bylaite M., Ackermann H., Ludwig R. J., Boehncke W.-H., Platelet P-selectin reflects a state of cutaneous inflammation: possible application to monitor treatment efficacy in psoriasis. Experimental Dermatology 2010 19 8 736 741 2-s2.0-77954858555 10.1111/j.1600-0625.2010.01095.x
24. Kurz K. D., Main B. W., Sandusky G. E., Rat model of arterial thrombosis induced by ferric chloride. Thrombosis Research 1990 60 4 269 280 2-s2.0-0025614358 10.1016/0049-3848(90)90106-M
25. Saucedo E. M., Pereira R. S., Barbosa G. M., Battisti V., Leal C. A., Fleck J., Santos R. C., Morsch V. M., Schetinger M. R., Leal D. B., Enzymes that hydrolyze adenine nucleotides in lymphocytes and platelets of immunosuppressed rats. Biomedicine & Pharmacotherapy 2010 64 6 437 440 2-s2.0-77954313987 10.1016/j.biopha.2010.01.014
26. 2+-stimulated ATPase activity. Analytical Biochemistry 1986 157 2 375 380 2-s2.0-0022549284
27. Broersma R. J., Kutcher L. W., Heminger E. F., The effect of thrombin inhibition in a rat arterial thrombosis model. Thrombosis Research 1991 64 4 405 412 2-s2.0-0026335337 10.1016/0049-3848(91)90341-S
28. Wang L., Miller C., Swarthout R. F., Rao M., Mackman N., Taubman M. B., Vascular smooth muscle-derived tissue factor is critical for arterial thrombosis after ferric chloride-induced injury. Blood 2009 113 3 705 713 2-s2.0-60249092962 10.1182/blood-2007-05-090944
29. Atkinson B., Dwyer K., Enjyoji K., Robson S. C., Ecto-nucleotidases of the CD39/NTPDase family modulate platelet activation and thrombus formation: potential as therapeutic targets. Blood Cells, Molecules, and Diseases 2006 36 2 217 222 2-s2.0-33645326900 10.1016/j.bcmd.2005.12.025
30. Cai M., Huttinger Z. M., He H., Zhang W., Li F., Goodman L. A., Wheeler D. G., Druhan L. J., Zweier J. L., Dwyer K. M., He G., d'Apice A. J. F., Robson S. C., Cowan P. J., Gumina R. J., Transgenic over expression of ectonucleotide triphosphate diphosphohydrolase-1 protects against murine myocardial ischemic injury. Journal of Molecular and Cellular Cardiology 2011 51 6 927 935 2-s2.0-80055116987 10.1016/j.yjmcc.2011.09.003
31. Enjyoji K., Sévigny J., Lin Y., Frenette P. S., Christie P. D., Am Esch J. S. II, Imai M., Edelberg J. M., Rayburn H., Lech M., Beeler D. L., Csizmadia E., Wagner D. D., Robson S. C., Rosenberg R. D., Targeted disruption of cd39 /ATP diphosphohydrolase results in disordered hemostasis and thromboregulation. Nature Medicine 1999 5 9 1010 1017 2-s2.0-0345540629 10.1038/12447